Skip to content

Resource Tags: HealthKick Invest 2020

Joel Finlayson

Partner, iGan Partners

Joel Finlayson is an Equity Partner with iGan Partners and the Managing Partner of iGan Advisory for portfolio companies. He has 20 years of strategy consulting & investing experience in healthcare & technology. Joel is an Associate of the Creative Destruction Lab in Toronto and a Director of the Royal College of Physicians & Surgeons […]

Read More
Jay Crone

Investment Director, Telus Ventures

Jay is responsible for sourcing, evaluating and executing innovative investment opportunities. He also works to enhance the financial and operational performance of the existing portfolio and is a Board observer for portfolio companies Taulia, Acorn Biolabs, and GenXys Health Care Systems. Before joining TELUS Ventures in 2018, Jay’s experience included roles in corporate finance and […]

Read More
Anne Woods

Managing Director, Life Sciences and Healthcare, Silicon Valley Bank

Anne Woods is the managing director of the Life Science and Healthcare practice for Silicon Valley Bank in Toronto where she is responsible for leading the bank’s efforts in this sector across Canada. In this role, she focuses on strengthening the bank’s position with leading-edge companies in Canada’s life science field. Anne finds this sector […]

Read More
Peter van der Velden

Managing General Partner, Lumira Ventures

With 28 years of investment and operating experience, Peter has participated in building companies from start-up through to expansion in the life sciences, information technology, and consumer sectors. Known as a results-oriented entrepreneur with demonstrated success in venture and buyout investing, transaction structuring and completion, strategic planning, business development, and operational management and restructuring, Peter […]

Read More
Elayne Wandler

Senior Director, adMare Academy, adMare Bioinnovations

Elayne brings over 20 years of executive and entrepreneurial experience to the role of Director, Programs and Partnerships. She has held a number of senior positions in the life sciences sector including market research, product management, and sales with Abbott Laboratories, a multi-national pharmaceutical company and then in corporate communications, investor relations, and business development […]

Read More
Michael Gietl

Industry Executive – Midwest and Canada Life Sciences and Healthcare Services, JP Morgan

Mike Gietl is an Executive Director with J.P. Morgan’s Life Sciences banking team, working with startup through small-cap companies in Minnesota and Canada. He focuses on companies in the medical device, pharmaceutical (generic and specialty), biosimilar, and tools and diagnostic spaces. Mike has over 17 years of experience at J.P. Morgan, including structuring and implementing […]

Read More
Tanja Dowe

CEO, Debiopharm Innovation Fund

Mrs. Dowe graduated from the Helsinki University of Technology (now Aalto University) where she obtained an MSc in Microbiology & Biochemistry in 2000. Tanja has always been interested in diagnostic and smart data solutions for precisions medicines. She has held several managing positions and has 18 years of experience in building business strategies, analyzing markets, […]

Read More
Anand Ganeshalingam

Senior Associate, iGan Partners

Anand is an Associate at iGan Partners. As a member of the investment team, he is responsible for leading deal sourcing, structuring, and diligence activities. He also works closely with existing portfolio companies, actively supporting with new transactions (financing and acquisitions) and strategic initiatives. He is a board observer for FlipGive, Limelight, and Medchart. Anand […]

Read More
Neil Klompas

CFO and EVP, Business Operations, Zymeworks

Mr. Klompas joined Zymeworks in March 2007 and currently serves as our Executive Vice President, Business Operations and Chief Financial Officer. Prior to joining Zymeworks, he worked with KPMG LLP in Canada and the United States, most recently (from 2005 to 2007) with KPMG’s Pharmaceuticals, Biotechnology and Medical Device M&A Transaction Services practice in Princeton, […]

Read More